Solis Pharmaceuticals

Hyderabad, India Founded: 2021 • Age: 5 yrs Acquired By PI Health Sciences
Manufacturer of drugs
Annual revenue $950,804 Latest available
Total funding - Funding intelligence
Employees 42 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Solis Pharmaceuticals

Solis Pharmaceuticals is a company based in Hyderabad (India) founded in 2021 was acquired by PI Health Sciences in June 2023. The company has 42 employees as of April 08, 2024.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $950.8 K (USD)
    6.93
    as on Mar 31, 2023
  • Net Profit
    $17.03 K (USD)
    -16.81
    as on Mar 31, 2023
  • EBITDA
    $72.97 K (USD)
    -4.91
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    42

    as on Apr 08, 2024

  • Acquired by
    PI Health Sciences

    (Jun 05, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Solis Pharmaceuticals

Premium access

Detailed funding history for Solis Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Solis Pharmaceuticals

Solis Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include PI Health Sciences.

All
Investor Description Founded Year Domain Location
Specializes in CRO and CDMO services for medicinal chemistry and API manufacturing.
Locked Locked Locked
Premium access

Investor details for Solis Pharmaceuticals

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Solis Pharmaceuticals

Investments
Premium access

Investment portfolio details for Solis Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Solis Pharmaceuticals

Premium access

Detailed financials for Solis Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Solis Pharmaceuticals Comparisons

Solis Pharmaceuticals Primary company
Description
Manufacturer of drugs
Location
Hyderabad, India
Founded Year
2021
Annual Revenue
$950.8 K (USD)
Net Profit
$17.03 K (USD)
EBITDA
$72.97 K (USD)
Employees
42
As of 2024
Premium access

Peer comparison for Solis Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Solis Pharmaceuticals

Premium access

Detailed competitors of Solis Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Solis Pharmaceuticals

Premium access

Complete news archive for Solis Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solis Pharmaceuticals

Solis Pharmaceuticals was founded in 2021.

Solis Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Apr 08, 2024, the latest employee count at Solis Pharmaceuticals is 42.

Annual revenue of Solis Pharmaceuticals is $950.8K as on Mar 31, 2023.

Solis Pharmaceuticals, established in 2021, excels in providing healthcare solutions, and traditional pharmaceuticals. Manufacturer of drugs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.

Solis Pharmaceuticals has 1 investor. Key investors include PI Health Sciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available